Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies

R. Sharma, M. Kacevska, Roslyn London, S.J. Clarke, C. Liddle, G. Robertson

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)


There is increasing evidence of a systemic inflammatory response associated with malignancy, which may have an impact on both drug disposition and resistance to cytotoxic therapy. The impact of inflammation on drug disposition was studied in mice bearing a number of common tumour xenografts. C57BL/6 mice were inoculated with tumour xenografts. Hepatic expressions of Cyp3a and drug transporters were analysed at the mRNA, protein and functional levels (Cyp3a only). Circulating serum cytokines and the hepatic expression of acute phase proteins (APPs) were measured. Intratumoral levels of multidrug resistance genes were determined. Tumour xenografts elicited an inflammatory response that coincided with repression in hepatic Cyp3a11 activity and the expression of a number of hepatic drug transporters. With tumour growth, a progressive reduction in hepatic Cyp3a11 mRNA expression was seen. Conversely, an increase in the hepatic APP expression and circulating interleukin ( IL)- 6 levels was observed. Furthermore, a correlation was seen between increased intratumoral expression of the multidrug resistance gene, Mdr1a, and levels of circulating IL-6. Malignancy results in reduced hepatic drug disposition that correlates with an associated inflammatory response. Reduction of inflammation may improve the clinical outcome for patients receiving chemotherapeutic agents that undergo hepatic metabolism.
Original languageEnglish
Pages (from-to)91-97
JournalBritish Journal of Cancer
Issue number1
Publication statusPublished - 2008


Dive into the research topics of 'Downregulation of drug transport and metabolism in mice bearing extra-hepatic malignancies'. Together they form a unique fingerprint.

Cite this